Efficacy of eletriptan in triptan-naïve patients: Results of a combined analysis

Headache

Volumn 47, Issue 2, 2007, Pages 181-188

  Martin, Vincent T ^a   Valade, Dominique ^b   Almas, Mary ^c   Hettiarachchi, Jayasena ^c   Sikes, Carolyn ^c   Albert, Kenneth S ^c   Parsons, Bruce ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b HÔPITAL LARIBOISIÈRE   (France)

^c PFIZER INC   (United States)

Author keywords

Eletriptan; Headache response; Migraine; Pain free response; Triptan experienced; Triptan na ve

Indexed keywords

CAFERGOT; ELETRIPTAN; NARATRIPTAN; PLACEBO; SUMATRIPTAN; ZOLMITRIPTAN;

ANALGESIA; ARTICLE; ASTHENIA; CLINICAL TRIAL; DIZZINESS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NAUSEA; PHONOPHOBIA; PHOTOPHOBIA; PRIORITY JOURNAL; SOMNOLENCE; SYMPTOM; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VOMITING;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEADACHE; HUMANS; MALE; MIDDLE AGED; PAIN; PYRROLIDINES; SEROTONIN AGONISTS; TIME FACTORS; TREATMENT OUTCOME; TRYPTAMINES;

EID: 33846989346     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00685.x     Document Type: Article

References (17)

1. Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache. 2001;41:646-657.
2. Rasmussen BK. Epidemiology of headache. Cephalalgia. 2001;21:774-777.
3. Menken M, Munsat TL, Toole JF. The global burden of disease study: Implications for neurology. Arch Neurol. 2000;57:418-420.
4. Silberstein SD. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55:754-763.
5. Lipton RB, Stewart WF, Stone AM, et al. Stratified care vs step care strategies formigraine:The disability in strategies of care (DISC) study: A randomized trial. JAMA. 2000;284:2599-2605.
6. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N Engl J Med. 2002;346:257-270.
7. Goadsby PJ, Ferrari MD, Olesen J, et al. Eletriptan in acute migraine: A double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Neurology. 2000;54:156-163.
8. Sandrini G, Färkkilä M, Burgess G, et al. Eletriptan vs sumatriptan: A double-blind, placebocontrolled, multiple migraine attack study. Neurology. 2002;59:1210-1217.
9. Mathew NT, Schoenen J, Winner P, et al. Comparative efficacy of eletriptan 40mg versus sumatriptan 100mg. Headache. 2003;43:214-222.
10. Diener HC, Jansen JP, Reches A, et al. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot®) in the acute treatment of migraine: A multicentre, randomised, double-blind, placebo-controlled comparison. Eur Neurol. 2002;47:99-107.
11. Steiner TJ, Diener HC, MacGregor EA, et al. Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine. Cephalalgia. 2003;23:942-952.
12. Stark R, Dahlöf C, Haughie S, et al. Efficacy, safety and tolerability of oral eletriptan in the acute treatment of migraine: Results of a phase III, multicentre, placebo-controlled study across three attacks. Cephalalgia. 2002;22:23-32.
13. Färkkilä M, Olesen J, Dahlöf C, et al. Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan. Cephalalgia. 2003;23:463-471.
14. Garcia-Ramos G, MacGregor EA, Hilliard B, et al. Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine. Cephalalgia. 2003;23:869-876.
15. Mathew NT, Hettiarachchi J, Alderman J. Tolerability and safety of eletriptan in the treatment of migraine: A comprehensive review. Headache. 2003;43:962-974.
16. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia. 2004;24(suppl 1):1-151.
17. SAS/STAT User's Guide, Version 6, 4th edn, SAS Institute, Inc., Cary, NC.